Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06310031 · ClinicalTrials.gov registry record · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
A NA study of Heart Failure and Cardiovascular Diseases, sponsored by BrioHealth Solutions.
- Recruiting
- Registry status
- NA
- Development phase
- 780
- Enrollment target
- 20
- Study locations
NCT06310031 is a NA study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by BrioHealth Solutions. The registered enrollment target is 780 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (62% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT06310031, a NA study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by BrioHealth Solutions.
- RECRUITING
- Registry status
- NA
- Development phase
- 780 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
Conditions Studied
Interventions
- DEVICE BrioVAD System
- DEVICE HeartMate 3
Study Locations (20)
Illinois
- Advocate Christ Medical Center - Chicago
- Northwestern University - Chicago
- University of Chicago - Chicago
Michigan
- University of Michigan - Ann Arbor
- Henry Ford Health - Detriot
- Corewell Health Grand Rapids Hospital - Grand Rapids
Florida
- UF Health Shands Hospital - Gainsville
- Advent Health - Orlando
Georgia
- Piedmont Healthcare - Atlanta
- Emory University - Atlanta
Minnesota
- Abbott Northwestern Hospital - Minneapolis
- University of Minnesota - Minneapolis
Arkansas
- Baptist Health Medical Center-Little Rock - Little Rock
Indiana
- Ascension St. Vincent Hospital - Indianapolis - Indianapolis
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06310031
The ClinicalTrials.gov registry entry for NCT06310031 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (62% lower). The listed sponsor is BrioHealth Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which BrioVAD System is the first listed.
NCT06310031 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Illinois, Michigan, Florida.
Frequently Asked Questions
What is clinical trial NCT06310031 about?
NCT06310031 is a clinical study titled "Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure". The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.
What is the current status of trial NCT06310031?
This trial is currently recruiting. It is a NA study. The enrollment target is 780 participants. The study started on 2024-10-28. Estimated completion is 2028-12.
What conditions does trial NCT06310031 study?
This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases, Heart Diseases.
What interventions are being tested in trial NCT06310031?
The interventions under investigation include: BrioVAD System (DEVICE), HeartMate 3 (DEVICE).
Who is sponsoring clinical trial NCT06310031?
This trial is sponsored by BrioHealth Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06310031 being conducted?
This trial has 20 study locations across Arkansas, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.